Natera (NTRA) Competitors $167.88 +5.78 (+3.57%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NTRA vs. DGX, FMS, HIMS, SHC, GH, OPCH, BTSG, VCYT, SGRY, and LFSTShould you be buying Natera stock or one of its competitors? The main competitors of Natera include Quest Diagnostics (DGX), Fresenius Medical Care (FMS), Hims & Hers Health (HIMS), Sotera Health (SHC), Guardant Health (GH), Option Care Health (OPCH), BrightSpring Health Services (BTSG), Veracyte (VCYT), Surgery Partners (SGRY), and LifeStance Health Group (LFST). These companies are all part of the "medical" sector. Natera vs. Quest Diagnostics Fresenius Medical Care Hims & Hers Health Sotera Health Guardant Health Option Care Health BrightSpring Health Services Veracyte Surgery Partners LifeStance Health Group Quest Diagnostics (NYSE:DGX) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, community ranking, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability. Is DGX or NTRA more profitable? Quest Diagnostics has a net margin of 8.82% compared to Natera's net margin of -14.01%. Quest Diagnostics' return on equity of 15.25% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Quest Diagnostics8.82% 15.25% 6.92% Natera -14.01%-26.23%-14.27% Does the MarketBeat Community prefer DGX or NTRA? Quest Diagnostics received 54 more outperform votes than Natera when rated by MarketBeat users. However, 68.78% of users gave Natera an outperform vote while only 49.21% of users gave Quest Diagnostics an outperform vote. CompanyUnderperformOutperformQuest DiagnosticsOutperform Votes53249.21% Underperform Votes54950.79% NateraOutperform Votes47868.78% Underperform Votes21731.22% Do analysts prefer DGX or NTRA? Quest Diagnostics currently has a consensus price target of $164.58, indicating a potential upside of 1.98%. Natera has a consensus price target of $140.59, indicating a potential downside of 16.26%. Given Quest Diagnostics' higher probable upside, equities research analysts clearly believe Quest Diagnostics is more favorable than Natera.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quest Diagnostics 0 Sell rating(s) 8 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.50Natera 0 Sell rating(s) 0 Hold rating(s) 17 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger valuation & earnings, DGX or NTRA? Quest Diagnostics has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuest Diagnostics$9.25B1.95$854M$7.4421.69Natera$1.08B20.47-$434.80M-$1.76-95.39 Does the media refer more to DGX or NTRA? In the previous week, Natera had 6 more articles in the media than Quest Diagnostics. MarketBeat recorded 26 mentions for Natera and 20 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 0.99 beat Natera's score of 0.82 indicating that Quest Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quest Diagnostics 11 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Natera 15 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, DGX or NTRA? Quest Diagnostics has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, Natera has a beta of 1.53, indicating that its stock price is 53% more volatile than the S&P 500. Do insiders and institutionals have more ownership in DGX or NTRA? 88.1% of Quest Diagnostics shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 0.8% of Quest Diagnostics shares are held by insiders. Comparatively, 7.6% of Natera shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryQuest Diagnostics beats Natera on 11 of the 19 factors compared between the two stocks. Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTRA vs. The Competition Export to ExcelMetricNateraMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.16B$2.99B$5.04B$8.82BDividend YieldN/A10.90%5.17%4.07%P/E Ratio-95.3916.50122.4217.58Price / Sales20.47257.891,179.2973.96Price / CashN/A373.0033.5632.51Price / Book26.354.924.694.68Net Income-$434.80M-$32.86M$118.98M$225.87M7 Day Performance4.29%-0.38%-2.45%-2.03%1 Month Performance37.16%-1.80%-4.03%0.07%1 Year Performance206.41%24.53%29.80%24.55% Natera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTRANatera2.8018 of 5 stars$167.88+3.6%$140.59-16.3%+206.4%$21.40B$1.08B-95.393,293Analyst ForecastDGXQuest Diagnostics4.9026 of 5 stars$161.38+0.1%$164.58+2.0%+19.7%$18.01B$9.25B21.6948,000Analyst DowngradeFMSFresenius Medical Care3.9521 of 5 stars$21.79-1.4%$24.30+11.5%+11.1%$12.97B$21.05B18.011,358Positive NewsHIMSHims & Hers Health3.5685 of 5 stars$21.80-7.4%$20.71-5.0%+181.8%$5.14B$872M49.551,046Analyst ForecastInsider TradeSHCSotera Health3.662 of 5 stars$13.21-2.9%$16.50+24.9%-5.2%$3.85B$1.05B52.843,000High Trading VolumeGHGuardant Health4.2798 of 5 stars$30.68flat$40.60+32.3%+28.4%$3.79B$563.95M0.001,779OPCHOption Care Health4.9784 of 5 stars$21.88+0.3%$30.83+40.9%-26.3%$3.71B$4.30B18.397,802Positive NewsBTSGBrightSpring Health Services2.9593 of 5 stars$18.79+0.8%$16.79-10.6%N/A$3.27B$10.59B-72.2735,000Positive NewsVCYTVeracyte4.1264 of 5 stars$39.20+0.1%$41.25+5.2%+50.5%$3.03B$361.05M-261.33790Analyst ForecastSGRYSurgery Partners3.0975 of 5 stars$22.51-1.1%$38.71+72.0%-29.9%$2.89B$2.74B0.0013,500Analyst ForecastLFSTLifeStance Health Group1.7828 of 5 stars$7.22-0.3%$8.50+17.7%+16.5%$2.77B$1.06B0.009,325 Related Companies and Tools Related Companies DGX Competitors FMS Competitors HIMS Competitors SHC Competitors GH Competitors OPCH Competitors BTSG Competitors VCYT Competitors SGRY Competitors LFST Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NTRA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NTRA Stock Alerts